Literature DB >> 10991559

Tumour markers in malignancies. Two isoforms of oestrogen receptor are now known to exist.

C Palmieri, S Fishpool, R C Coombes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10991559      PMCID： PMC1118342     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Estrogen receptor beta--a new dimension in estrogen mechanism of action.

Authors:  J A Gustafsson
Journal:  J Endocrinol       Date:  1999-12       Impact factor: 4.286

Review 2.  Hormonal therapy of breast cancer.

Authors:  G Y Locker
Journal:  Cancer Treat Rev       Date:  1998-06       Impact factor: 12.111

3.  Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.

Authors:  T A Järvinen; M Pelto-Huikko; K Holli; J Isola
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 4.  Regular review: tumour markers in malignancies.

Authors:  A Lindblom; A Liljegren
Journal:  BMJ       Date:  2000-02-12

Review 5.  The management of stage I testis cancer.

Authors:  C N Sternberg
Journal:  Urol Clin North Am       Date:  1998-08       Impact factor: 2.241

6.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

7.  Risk and prognostic factors in trophoblastic neoplasia.

Authors:  K D Bagshawe
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.